CompoAtlas

COLLAGEN MAX SUPERFRUITS

Food supplement declared in France, declaration No 2022-12-351, decision dated 7 December 2022

COLLAGEN MAX SUPERFRUITS is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
BIOCYTE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
1 dose de 13g par jour
Directions for use
Ajouter 13 g (2 cuillères doseuses arasées) dans 150 mL d’eau et mélanger jusqu’à dissolution
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Skin
Flavourings
fruits rouges menthe

Declaration 190155, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Euterpe oleracea Mart.FruitExtrait sec aqueux250 mg
Malpighia glabra L.FruitPression à froid180 mg

Other active ingredients

NamePer day
Hydrolysat de collagène bovinnot declared
Hyaluronate de sodiumnot declared

Additives

E296, E160a, E504, E960

Other ingredients

Beta vulgaris L., maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Euterpe oleracea Mart.
    Read the warning, when it applies and the studies cited

    ACAI – EUTERPE OLERACEA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).

    Sources cited by Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).

    Sources cited by Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line